{"id":5745,"date":"2024-01-04T16:01:14","date_gmt":"2024-01-04T16:01:14","guid":{"rendered":"https:\/\/aceoncology.org\/?post_type=ace_education&#038;p=5745"},"modified":"2024-10-21T20:07:40","modified_gmt":"2024-10-21T20:07:40","slug":"clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer","status":"publish","type":"ace_education","link":"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/","title":{"rendered":"Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer"},"content":{"rendered":"\n<p>The therapeutic landscape of advanced urothelial cancer has undergone a significant transformation in recent years with the addition of PD-1\/PD-L1 targeting immune checkpoint inhibitors and novel antibody-drug conjugates to the treatment armamentarium. In this Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer, experts in the field will discuss the latest evidence supporting the use of these therapies in clinical practice, including patient selection for cisplatin\/carboplatin eligible and platinum ineligible and optimal treatment strategy in the first-line setting, sequencing of treatments and the management of treatment-related adverse events. An improved understanding of the role and application of immunotherapy, chemotherapy, antibody-drug conjugates (ADC) and targeted treatments to routine patient care will facilitate optimal management of patients with urothelial cancer.<\/p>\n\n\n\n<div style=\"height:5px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>This program is available with subtitles in the following languages:<\/p>\n\n\n\n<div style=\"height:5px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"241\" height=\"55\" src=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/02\/flags-DE-IT-FR-ES-JN.png\" alt=\"\" class=\"wp-image-5829\"\/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>The therapeutic landscape of advanced urothelial cancer [&hellip;]<\/p>\n","protected":false},"author":719,"featured_media":5774,"template":"","ace_education_category":[35,68],"ace_education_tag":[],"class_list":["post-5745","ace_education","type-ace_education","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer - ACE Oncology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"The therapeutic landscape of advanced urothelial cancer [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-21T20:07:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/01\/CI_TreatmentAlgorithm_social_01_1200x628.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/\",\"name\":\"Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/01\/CI_TreatmentAlgorithm_social_01_1200x628.jpg\",\"datePublished\":\"2024-01-04T16:01:14+00:00\",\"dateModified\":\"2024-10-21T20:07:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/01\/CI_TreatmentAlgorithm_social_01_1200x628.jpg\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/01\/CI_TreatmentAlgorithm_social_01_1200x628.jpg\",\"width\":1200,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u5728\u7ebf\u6559\u80b2\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/education\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer - ACE Oncology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/","og_locale":"zh_CN","og_type":"article","og_title":"Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer - ACE Oncology","og_description":"The therapeutic landscape of advanced urothelial cancer [&hellip;]","og_url":"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/","og_site_name":"ACE Oncology","article_modified_time":"2024-10-21T20:07:40+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/01\/CI_TreatmentAlgorithm_social_01_1200x628.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@ace_oncology","twitter_misc":{"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/","url":"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/","name":"Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/01\/CI_TreatmentAlgorithm_social_01_1200x628.jpg","datePublished":"2024-01-04T16:01:14+00:00","dateModified":"2024-10-21T20:07:40+00:00","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/01\/CI_TreatmentAlgorithm_social_01_1200x628.jpg","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2024\/01\/CI_TreatmentAlgorithm_social_01_1200x628.jpg","width":1200,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/education\/clinical-insights-of-treatment-algorithm-in-unresectablelocally-advanced-or-metastatic-urothelial-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"\u5728\u7ebf\u6559\u80b2","item":"https:\/\/aceoncology.org\/zh-hans\/education\/"},{"@type":"ListItem","position":3,"name":"Clinical Insights on the Treatment Algorithm in Unresectable Locally Advanced or Metastatic Urothelial Cancer"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_education\/5745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_education"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/ace_education"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/719"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/5774"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=5745"}],"wp:term":[{"taxonomy":"ace_education_category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_education_category?post=5745"},{"taxonomy":"ace_education_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_education_tag?post=5745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}